Genprex, Inc. (GNPX)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

10 annual periodsNewest to oldest
2025202420232022202120202019201820172016
Revenue$0$0$0$0$0$0$0$0
Research & development$9.4M$10.5M$17.6M$11.5M$9.0M$7.3M$2.0M$971,427$289,934$354,883
Operating income−$15.5M−$21.2M−$31.1M−$23.8M−$20.7M−$18.0M−$10.7M−$12.4M−$3.3M−$4.1M
EBITDAderived−$20.4M−$31.0M
Net income−$16.2M−$21.1M−$30.9M−$23.7M−$20.7M−$17.9M−$10.7M−$12.4M−$3.3M−$4.1M
Basic EPSper diluted share-$17.40-$266.89-$22.56-$19.80-$0.44-$0.51-$0.66-$0.90-$0.29-$0.38
Diluted EPSper diluted share-$0.42-$0.51-$0.66-$0.90-$0.29-$0.38

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)2$22.14 disclosed value
2 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Apr 14, 2026Form 4LONGNECKER BRENT MDirectorSellCommon Stock · indirect10$1.23$12.300
Apr 14, 2026Form 4LONGNECKER BRENT MDirectorSellCommon Stock8$1.23$9.849.2K